Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier ...

Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be built ...

Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

Saga PLC - Kent, England-based provider of products and services for people over 50 - Announces that its 20-year motor and home insurance partnership with Ageas UK, wholly-owned subsidiary of Ageas SA ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support ...